Eli Lilly and Company

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 11 Apr 2018
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

750,000€

Financial year: Jan 2017 - Dec 2017

Lobbyists (Full time equivalent)

1.75 Fte (4)

Lobbyists with EP accreditation

2

High-level Commission meetings

18

Lobbying Costs over the years

  • Info

    Eli Lilly and Company   (Lilly)

    EU Transparency Register

    04657143399-39 First registered on 02 Apr 2010

    Goals / Remit

    Lilly is a leading innovative biopharmaceutical company that unites caring with discovery to make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

    Headquartered in the US, Lilly has approximately 40,660 employees worldwide with approximately 22,240 based outside the US. In 2017 global revenue was approx. $22.87 billion, of which c.23% were invested in R&D.

    ( https://investor.lilly.com/financials.cfm )

    Elanco is the animal health business unit of Lilly. Elanco is an innovation-based company which makes life sciences work better for people by transforming animal protein production and companion animal care. Elanco operates in more than 70 countries worldwide, focusing on products for companion animal and food animal health, vaccines, parasiticides, enzymes, diagnostics and aquaculture.

    Both are part of Lilly as a single legal entity.

    Main EU files targeted

    Jobs and Growth; Science and Innovation; Public Health; Sustainable Healthcare; eHealth; Human and animal healthcare legislation; Intellectual Property; European Medicines Agency; Data Privacy, Clinical Trials Regulation; Health Technology Assessment including EUnetHTA; Transparency Directive; Falsified Medicines Directive; Trade including Trans-Atlantic, CETA and Brexit; Industrial policy; Competition; Taxation; Environment including REACH and PIE; Innovative Medicines Initiative; AMR; Horizon 2020; Biosimilars; Transparency Register; European Semester.

    Address

    Head Office
    Lilly Corporate Centre
    Indianapolis
    Indianapolis 46285
    UNITED STATES
    EU Office
    Rue du Marquis 1
    Brussels B-1000
    BELGIUM
  • People

    Total lobbyists declared

    4

    Employment timeLobbyists
    50%3
    25%1

    Lobbyists (Full time equivalent)

    1.75

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    2 accreditations were / are live (in bold) for the selected state of 11 Apr 2018

    Name Start date End Date
    Ms Fanny VERSPEELT 16 Feb 2024 14 Feb 2025
    Mr Pierluca ARIETTI 16 Dec 2023 21 Mar 2024
    Mr Maurizio GUIDI 15 Dec 2023 13 Dec 2024
    Ms Antonella ETTORRE 15 Dec 2023 13 Dec 2024
    Ms Aoife Gallagher 15 Dec 2023 13 Dec 2024
    Ms Doris Schernhammer 15 Dec 2023 13 Dec 2024
    Ms Aoife Gallagher 25 Jan 2023 15 Dec 2023
    Ms Doris Schernhammer 25 Jan 2023 15 Dec 2023
    Ms Antonella ETTORRE 24 Jan 2023 15 Dec 2023
    Mr Goncalo FERREIRA-PINTO-MENDES 24 Nov 2022 06 May 2023
    Mr Pierluca ARIETTI 19 Nov 2022 18 Nov 2023
    Mr Maurizio GUIDI 19 Nov 2022 18 Nov 2023
    Ms Sonia Ujupan 24 Sep 2022 23 Sep 2023
    Mr Goncalo PINTO MENDES 20 Oct 2021 20 Oct 2022
    Ms Doris Schernhammer 13 May 2021 13 May 2022
    Ms Aoife Gallagher 11 May 2021 11 May 2022
    Ms Sonia Ujupan 05 Mar 2021 05 Mar 2022
    Mr Gerd KRAH 27 Feb 2020 27 Feb 2021
    Ms Sonia Ujupan 05 Feb 2020 05 Feb 2021
    Ms Aoife Gallagher 03 Oct 2019 03 Oct 2020
    Ms Arantzazu MUGICA GOICOECHEA 30 Mar 2019 01 Apr 2020
    Ms Sonia Ujupan 28 Nov 2018 19 Nov 2019
    Ms Doris Schernhammer 10 Nov 2018 09 Nov 2019
    Mr Davide RUFFO 09 Nov 2018 09 Nov 2019
    Ms Aoife Gallagher 24 May 2018 24 May 2019
    Ms Sonia Ujupan 13 Nov 2017 20 Oct 2018
    Ms Doris Schernhammer 01 Nov 2017 31 Oct 2018
    Ms Doris Schernhammer 22 Nov 2016 01 Nov 2017
    Ms Aoife Gallagher 22 Nov 2016 19 Nov 2017
    Ms Sonia Ujupan 16 Nov 2016 13 Nov 2017
    Ms Elisa Irlandese 15 Sep 2016 14 Sep 2017
    Mr Olivier ESPEISSE 14 Jan 2016 13 Jan 2017
    Ms Doris Schernhammer 13 Jan 2016 22 Nov 2016
    Ms Athanasia Kanli 17 Nov 2015 12 Nov 2016
    Ms Aoife Gallagher 23 Jul 2015 20 Jul 2016
    Ms Doris Schernhammer 27 Jan 2015 13 Jan 2016
    Ms Athanasia Kanli 10 Dec 2014 17 Nov 2015
    Mr Alexander Josef ANTON 04 Apr 2013 19 Nov 2013
    Mr Hugh Thomas PULLEN 26 Mar 2013 23 Mar 2014
    Mr Alexander Josef ANTON 24 Feb 2012 01 Mar 2013
    Mr Hugh Thomas PULLEN 24 Feb 2012 01 Mar 2013

    Complementary Information

    Note: 3 colleagues are full-time engaged in the Brussels office / Elanco, and 1 outside Brussels, and will spend approx 25% - 50% of their time on relevant EU affairs. A few other colleagues whereas spend a fraction of their time (0-5%).

    Person in charge of EU relations

    Ms Aoife Gallagher (Head European Government Affairs and Brussels office)

    Person with legal responsibility

    Mr David Ricks (Chairman and CEO)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    Eli Lilly and Company is a member of the following associations and bodies: EFPIA, EuropaBio, AmChamEU, Trans-Atlantic Business Council, American European Community Association, Trans-Atlantic Policy Network, ASOP Global, Animal Health Europe, The European Feed Manufacturers Federation(FEFAC), EU40.

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2017 - Dec 2017

    Lobbying costs for closed financial year

    750,000€

    Other financial info

    This estimate is calculated according to pro rata staffing and office costs of Eli Lilly and Company staff involved in interest representation towards the European institutions as defined under the Register, based on the proportion of employee time devoted to these activities. In accordance with the Transparency Register Compliance guidelines on financial information, this estimate of costs as a range includes fees paid for outsourced activities (i.e consultancy contract fees). The estimate includes relevant membership fees to the various trade associations and other bodies. The list is included in the membership section of this form.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    None

    Communication activities

    None

    Other activities

    Health Outcomes, Real World Evidence, Pricing, Reimbursement and Access to medicines, European Medicines Agency, European Chemicals Agency, biopharmaceuticals, healthcare, global health, innovation and research, veterinary medicine, business competitiveness, clinical trials transparency, patient advocacy group payments, transfers of value to healthcare professionals and healthcare organisations.

  • Meetings

    Meetings

    18 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard